Manf Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Mesencephalic Astrocyte-Derived Neurotrophic Factor (ARMET)
| Protein Name | MANF (ARMET) |
|---|---|
| Gene | MANF |
| UniProt ID | Q99986 |
| PDB ID | 2K3P, 2VYO |
| Molecular Weight | 20 kDa (182 amino acids) |
| Subcellular Localization | Secreted, Endoplasmic Reticulum, Cytoplasm |
| Protein Family | ARMET family (unique neurotrophic factors) |
MANF (Mesencephalic Astrocyte-Derived Neurotrophic Factor), also known as ARMET (Arginine-rich, Mutated in Early stage Tumors), is a secreted neurotrophic factor that plays critical roles in neuronal survival, ER homeostasis, and protein quality control. Discovered in 2003, MANF represents a unique class of neurotrophic factors distinct from the traditional GDNF family. It has emerged as a promising therapeutic target for Parkinson's disease, Alzheimer's disease, and various ER stress-related disorders.
MANF is unique among neurotrophic factors because it can function both intracellularly (in the ER and cytoplasm) and as a secreted extracellular signaling molecule. This dual functionality makes it particularly interesting for neurodegenerative disease research.
MANF is a 182-amino acid protein with a distinctive bipartite structure:
N-terminal domain (1-60 aa): Contains an ER retention signal sequence (RTDL) that directs protein to the endoplasmic reticulum. This region is rich in arginine residues and contributes to protein-protein interactions.
C-terminal domain (61-182 aa): The secreted portion of MANF contains the neurotrophic activity. This domain adopts a stable three-dimensional fold with disulfide bonds that maintain structural integrity.
Cys-rich regions: Four conserved cysteine residues form two disulfide bonds (Cys71-Cys98 and Cys103-Cys133), creating a cysteine-pair motif characteristic of the MANF family.
Signal peptide (1-23 aa): Enables secretion via the classical secretory pathway when the ER retrieval signal is not engaged.
The crystal structure reveals a novel protein fold distinct from other known neurotrophic factors, making MANF a unique therapeutic agent.
MANF exerts neuroprotective effects through multiple molecular mechanisms:
MANF is primarily localized to the endoplasmic reticulum where it functions as a chaperone protein. It directly binds to misfolded proteins and helps maintain ER homeostasis. MANF interacts with the major ER chaperone BiP/GRP78 and modulates the unfolded protein response (UPR).
When secreted, MANF binds to specific receptors on neurons to promote survival and regeneration:
MANF modulates neuroinflammation through:
MANF shows region-specific expression in the brain:
MANF-based therapies are being developed for neurodegenerative diseases:
The study of Manf Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.